ResMed | RMD - Operating Profit


ResMed reported $497.6M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Ansell USD 58.65M 19.15M Jun/2024
Artivion USD 4.39M 2.12M Sep/2024
AtriCure USD 2.49M 2.28M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Cochlear AUD 125.55M 149.05M Jun/2025
Cooper Companies USD 140.4M 35.3M Sep/2025
CSL USD 666M 1.31B Jun/2025
Dexcom USD 323M 80.5M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
Fisher Paykel Healthcare NZD 298.2M 2.8M Dec/2025
Globus Medical USD -117.52M 8.43M Sep/2025
Haemonetics USD 67.4M 8.9M Dec/2025
Hologic USD 237M 16M Dec/2025
Idexx Laboratories USD 315.6M 39.24M Dec/2025
Inogen USD -7.79M 728K Sep/2024
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 11.76M 13.07M Sep/2025
Intuitive Surgical USD 865.3M 97.5M Dec/2025
Masimo USD 83.6M 19.1M Sep/2025
Medtronic USD 1.74B 40M Dec/2025
Philips EUR 719M 390M Dec/2025
Ramsay Health Care AUD 537.2M 337.2M Jun/2025
ResMed USD 497.6M 35.25M Dec/2025
Sigma Healthcare AUD 809K 13.76M Dec/2024
Sonic Healthcare AUD 435.76M 193.66M Dec/2024
Steris USD 278M 7.1M Dec/2025
Teleflex USD -408.9M 586.38M Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025